10 June 2021

The Erwin L. Hahn Institute for Magnetic Resonance Imaging (ELH) in Essen is dedicated to research, development and application of ultra-high field magnetic resonance imaging (UHF-MRI). The ELH was founded as a central institution of the University of Duisburg-Essen and the Radboud University in 2005. For many years scientists Tom Scheenen and Prof. David Norris of the department of Medical Imaging of the Radboudumc and of the Donders Centre for Cognitive Neuroimaging have been leading Radboud-related research on one of the first ultra-high field whole body MRI systems in Europe.

Recently, the ELH has received a new heart: a 20-ton ultra-high-field magnetic resonance scanner from Siemens Healthcare (MAGNETOM Terra) with a magnetic field strength of 7 Tesla. Despite ongoing restrictions due to the Corona pandemic, the new CE-approved 7T MRI is now ready for business, and projects on body and brain imaging are starting up. The first scans on humans have already taken place - Prof. Harald Quick, who had acquired the MRI system costing a good 7.5 million euros on behalf of the ELH with funding from the German Research Foundation (DFG), did not miss the opportunity to be the first person being examined.

Compared to the MRI systems in our UMC and Donders Centre with 1.5 and 3.0 Tesla field strengths, the 7 Tesla UHF MRI system provides a much higher sensitivity for measurements in the human body and brain, which can be used to scan at very high spatial resolution. The new MRI scanner at ELH is faster and more powerful than its predecessor, despite having the same field strength, thus ensuring that scientists on site can continue to conduct cutting-edge research in the future.

On October 21, the new MRI scanner will be presented and officially inaugurated during the annual Erwin L. Hahn Workshop & Lecture. 

Moving in the new magnet

The new 7T system in place

The first human in vivo brain scan

Related news items


On the prevalence of cerebral amyloid angiopathy a systematic review and meta-analysis

10 June 2021

Published in ‘Alzheimers and Dementia’, researchers at Radboudumc performed a systematic review and meta-analysis on the prevalence of Cerebral Amyloid Angiopathy. They scrutinized and analyzed 170 publications, comprising publications using either a neuroimaging or a neuropathological approach.

read more

Retina-on-chip modeling and treating eye diseases in a dish

10 June 2021

Alex Garanto, together with Anneke den Hollander and Andries van der Meer (UTwente) have received 1,17M€ to develop a retina-on-chip model to improve our understanding in eye diseases and to develop treatments against them.

read more

New method to prevent ovarian cancer increases quality of life

8 June 2021

Researchers at Radboudumc have shown that quality of life is better in women with a BRCA1 or BRCA2 mutation after fallopian tube removal with delayed ovarian removal to prevent ovarian cancer.

read more

Radboud Pluim for Dagmar Eleveld-Trancikova Policy advisor of the three research institutes

8 June 2021

Radboudpluim for research policy adviser Dagmar Eleveld-Trancikova.

read more

Epidemiology and reporting characteristics of preclinical systematic reviews in PLoS Biology

7 June 2021

Kim Wever, researcher of the department of Health Evidence and an international team published the article 'Epidemiology and reporting characteristics of preclinical systematic reviews' in PLoS Biology.

read more